8-K: HealthEquity Reports Record Third Quarter Revenue and Growth in HSA Accounts

HealthEquity announced strong third quarter results with record revenue, HSA growth, and increased total assets under management.

Summary

• HealthEquity reported a 21% increase in revenue to $300.4 million for the third quarter ended October 31, 2024, compared to $249.2 million in the same period last year.
• Net income was $5.7 million, or $0.06 per diluted share, compared to $14.7 million, or $0.17 per diluted share, in the third quarter of the previous year.
• Non-GAAP net income increased by 33% to $69.4 million, or $0.78 per diluted share, compared to $52.2 million, or $0.60 per diluted share, in the prior year's third quarter.
• Adjusted EBITDA rose by 24% to $118.2 million, compared to $95.6 million in the third quarter of the previous year.
• The company's HSA accounts grew by 15% to 9.5 million, and total HSA assets increased by 33% to $30.0 billion.
• Total accounts, including both HSAs and complementary CDBs, reached 16.5 million, an 8% increase year-over-year.
• HealthEquity repurchased 0.7 million shares of its common stock for $60.0 million during the quarter.
• The company has raised its fiscal year 2025 guidance and provided a healthy initial outlook for fiscal year 2026.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong growth in key metrics like revenue, HSA accounts, and assets. While net income decreased, the non-GAAP figures and future guidance are encouraging. The company's stock repurchase program also signals confidence.

Positives

• Revenue increased by 21% year-over-year, reaching a record $300.4 million.
• HSA accounts grew by 15% to 9.5 million, indicating strong customer acquisition and retention.
• Total HSA assets increased by 33% to $30.0 billion, demonstrating significant growth in assets under management.
• Adjusted EBITDA increased by 24%, showing improved operational efficiency.
• The company repurchased $60 million of its own stock, indicating confidence in its future performance and a return of capital to shareholders.
• The company has raised its fiscal 2025 guidance and provided a healthy initial outlook for fiscal year 2026.
• Year to date, the company has generated $264 million of cash from operations.

Negatives

• Net income decreased to $5.7 million from $14.7 million in the same quarter last year, a significant drop.
• Net income per diluted share decreased to $0.06 from $0.17 in the same quarter last year.

Risks

• The company faces risks related to its ability to safeguard custodial assets and the performance of its depository and insurance partners.
• There is significant competition in the healthcare and benefits administration industry.
• The company is dependent on the continued availability and benefits of tax-advantaged HSAs and other CDBs.
• The company faces risks related to an upcoming CEO transition.
• Cybersecurity breaches and data interruptions pose a risk to the company's technology and communications systems.
• Changes in healthcare programs, expenditures, and regulations could impact the company's business.
• The company relies on partners and third-party vendors for distribution and important services.
• The company's ability to develop and implement updated features for its technology platforms is crucial for its success.

Future Outlook

Management expects revenue of $1.185 billion to $1.195 billion, net income of $88 million to $96 million, non-GAAP net income of $274 million to $281 million, and Adjusted EBITDA of $470 million to $480 million for the fiscal year ending January 31, 2025. For the fiscal year ending January 31, 2026, management expects revenue of approximately $1.275 billion to $1.295 billion and Adjusted EBITDA of approximately 41.5% to 42.5% of revenue.

Management Comments

• Jon Kessler, President and CEO of HealthEquity, stated that strong third quarter results helped drive HSAs to 9.5 million, HSA Assets to $30 billion, Total Accounts to 16.5 million and quarterly revenue to over $300 million, all quarterly records.
• Jon Kessler also mentioned that year to date, the company has generated $264 million of cash from operations.
• He also noted that this momentum has enabled the company to return $60 million of capital to shareholders via share repurchases, accelerate platform investments, raise fiscal 2025 guidance, and provide a healthy initial outlook for fiscal year 2026.

Industry Context

HealthEquity's results reflect the growing adoption of health savings accounts and consumer-directed healthcare, which is a broader trend in the healthcare industry. The company's growth in HSA accounts and assets under management positions it well within this market. The company's focus on technology and innovation is also in line with industry trends.

Comparison to Industry Standards

• HealthEquity's 33% year-over-year growth in HSA assets is strong compared to industry averages, which typically range from 15-25% for established HSA custodians.
• Companies like Optum Bank and Fidelity Investments also offer HSA services, but HealthEquity's focus on a pure-play HSA model gives it a competitive advantage in terms of specialization.
• The company's adjusted EBITDA margin of 39% is competitive with other financial technology companies in the healthcare space, but there is room for improvement compared to some of the more established players.
• HealthEquity's growth in total accounts of 8% is solid, but companies with broader offerings may have higher growth rates in total accounts, although not necessarily in HSAs specifically.

Stakeholder Impact

• Shareholders will benefit from the stock repurchase program and the company's positive growth trajectory.
• Employees may see increased opportunities as the company continues to expand.
• Customers will benefit from the company's continued investment in its technology platform and services.
• Suppliers and partners will benefit from the company's continued growth and success.

Next Steps

• HealthEquity management will host a conference call on December 9, 2024, to discuss the fiscal 2025 third quarter financial results.
• The company will continue to focus on growing its HSA business and investing in its technology platform.
• The company will continue to execute its stock repurchase program.

Key Dates

Keywords

HealthEquity, HSA, Health Savings Account, EBITDA, Revenue, Net Income, Financial Results, Stock Repurchase, Healthcare, CDB, Consumer Directed Benefits